Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Genome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

Molecular genetic testing, specifically genome sequence analysis, is a sophisticated procedure that delves into the genetic makeup of an individual to identify potential heritable disorders or syndromes. This testing focuses on both coding and non-coding regions of DNA, which are crucial for understanding genetic functions and variations. Whole genome sequencing (WGS) is a comprehensive approach that allows for the examination of the entire genome, making it a valuable tool for diagnosing rare genetic disorders, particularly in patients who exhibit atypical symptoms or characteristics. Additionally, WGS can be utilized by healthy individuals who wish to determine their carrier status for familial diseases or assess their risk for developing adult-onset medical conditions. The process begins with the collection of a blood sample, which is obtained through a separately reportable venipuncture. Following this, advanced techniques such as next-generation sequencing are employed to analyze the DNA. The results of this analysis are reported using CPT® Code 81425, which specifically denotes the genome sequence analysis for unexplained constitutional or heritable disorders or syndromes.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The genome sequence analysis is indicated for the following conditions and scenarios:

  • Unexplained Constitutional Disorders This analysis is performed when patients present with symptoms that do not fit into a known syndrome or disorder, allowing for the identification of potential genetic causes.
  • Heritable Syndromes It is indicated for individuals suspected of having a heritable syndrome based on their clinical presentation, enabling the detection of genetic mutations that may be passed down through families.
  • Carrier Status Identification Healthy individuals may seek this testing to determine if they are carriers of genetic conditions that could affect their offspring.
  • Predisposition to Adult-Onset Conditions The analysis can also be utilized to identify genetic predispositions to conditions that may manifest later in life, aiding in preventive healthcare strategies.

2. Procedure

The procedure for genome sequence analysis involves several critical steps to ensure accurate results:

  • Step 1: Sample Collection A blood sample is obtained from the patient through a venipuncture, which is a standard procedure for collecting blood for laboratory testing. This sample serves as the source of DNA for subsequent analysis.
  • Step 2: DNA Extraction Once the blood sample is collected, the DNA is extracted from the blood cells. This process involves breaking down the cell membranes and isolating the DNA, which is essential for the next steps of the analysis.
  • Step 3: Next-Generation Sequencing The extracted DNA undergoes next-generation sequencing (NGS), a high-throughput method that allows for rapid sequencing of large amounts of DNA. This technology enables the identification of variations across the entire genome, including both coding and non-coding regions.
  • Step 4: Data Analysis The sequencing data is then analyzed using bioinformatics tools to interpret the genetic variations identified. This analysis helps in determining whether any of the identified genetic changes are associated with the patient's symptoms or conditions.
  • Step 5: Reporting Results Finally, the results of the genome sequence analysis are compiled into a report, which is then communicated to the healthcare provider. This report includes information on any identified genetic variants and their potential implications for the patient's health.

3. Post-Procedure

After the genome sequence analysis is completed, patients may receive counseling regarding the results, especially if significant genetic variants are identified. This counseling can help patients understand the implications of their genetic information, including potential health risks and the options available for management or further testing. Additionally, follow-up appointments may be necessary to discuss the findings in detail and to consider any further actions, such as genetic counseling for family members or additional testing for related conditions. It is important for patients to be aware that the interpretation of genetic data can evolve over time as new research emerges, and re-evaluation of the results may be warranted in the future.

Short Descr GENOME SEQUENCE ANALYSIS
Medium Descr GENOME SEQUENCE ANALYSIS
Long Descr Genome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Service Paid under Fee Schedule or Payment System other than OPPS
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1

This is a primary code that can be used with these additional add-on codes.

81426 Addon Code MPFS Status: Statutory exclusion (from MPFS, may be paid under other methodologies) APC A Genome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis, each comparator genome (eg, parents, siblings) (List separately in addition to code for primary procedure)
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
GA Waiver of liability statement issued as required by payer policy, individual case
Date
Action
Notes
2015-01-01 Added Added
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"